European meeting "P2 receptors: New targets for the treatment of osteoporosis"

Purinergic Signalling

Volumn 7, Issue 2, 2011, Pages 275-276

  Jørgensen, Niklas Rye ^a   Boeynaems, Jean Marie ^b   Di Virgilio, Francesco ^c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961001726     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9223-1     Document Type: Article

References (5)

1. Hoeberz A, Arnett TR, Burnstock G (2003) Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 24: 290-297.
2. Burnstock G, Arnett TR (eds) (2006) Nucleotides and regulation of bone cell function. Taylor & Francis, Boca Raton.
3. Orriss IR, Burnstock G, Arnett TR (2010) Purinergic signalling and bone remodelling. Curr Opin Pharmacol 10: 322-30.
4. Orriss I, Syberg S, Wang N, Robaye B, Gartland A, Jorgensen N, Arnett T, Boeynaems J-M (2011) Bone phenotypes shown by P2 receptor knockout mice. Frontiers in Bioscience (in press).
5. Pellegatti P, Falzoni S, Pinton P, Rizzuto R, Di Virgilio F (2005) A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol Biol Cell 16: 3659-65.